H. Strongman

First name
Last name
Strongman, H., Gadd, S., Matthews, A. A., Mansfield, K. E., Stanway, S., Lyon, A. R., et al. (2022). Does Cardiovascular Mortality Overtake Cancer Mortality During Cancer Survivorship?: An English Retrospective Cohort Study. Jacc Cardiooncol, 4, 113-123. http://doi.org/10.1016/j.jaccao.2022.01.102
Strongman, H., Carreira, H., De Stavola, B. L., Bhaskaran, K., & Leon, D. A. (2022). Factors associated with excess all-cause mortality in the first wave of the COVID-19 pandemic in the UK: A time series analysis using the Clinical Practice Research Datalink. Plos Med, 19, e1003870. http://doi.org/10.1371/journal.pmed.1003870
Herrett, E., Strongman, H., Gadd, S., Tomlinson, L., Nitsch, D., Bhaskaran, K., et al. (2022). The importance of blood pressure thresholds versus predicted cardiovascular risk on subsequent rates of cardiovascular disease: a cohort study in English primary care. Lancet Healthy Longev, 3, e22-e30. http://doi.org/10.1016/s2666-7568(21)00281-6
Das, R., Langerman, H., D'Oca, K., & Strongman, H. (2014). An Observational Cohort Study of Diabetes-Associated Secondary Health Care Utilisation in Patients With Type 2 Diabetes Prescribed Dual Combination Therapy With Oral Anti-Hyperglycaemic Agents in the UK. Value Health. http://doi.org/10.1016/j.jval.2014.08.782
Strongman, H., D'Oca, K., Langerman, H., & Das, R. (2015). Comparison of diabetes-associated secondary healthcare utilization between alternative oral antihyperglycaemic dual therapy combinations with metformin in patients with type 2 diabetes: an observational cohort study. Diabetes Obes Metab. http://doi.org/10.1111/dom.12458
Korhonen, P., Heintjes, E. M., Williams, R., Hoti, F., Christopher, S., Majak, M., et al. (2016). Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries. Bmj. http://doi.org/10.1136/bmj.i3903
Strongman, H., Korhonen, P., Williams, R., Bahmanyar, S., Hoti, F., Christopher, S., et al. (2017). Pioglitazone and risk of mortality in patients with type 2 diabetes: results from a European multidatabase cohort study. BMJ Open Diabetes Res Care. http://doi.org/10.1136/bmjdrc-2016-000364
Chidwick, K., Strongman, H., Matthews, A., Stanway, S., Lyon, A. R., Smeeth, L., & Bhaskaran, K. (2018). Statin use in cancer survivors versus the general population: cohort study using primary care data from the UK clinical practice research datalink. BMC Cancer. http://doi.org/10.1186/s12885-018-4947-8
Strongman, H., Kausar, I., & Maher, T. M. (2018). Incidence, Prevalence, and Survival of Patients with Idiopathic Pulmonary Fibrosis in the UK. Adv Ther. http://doi.org/10.1007/s12325-018-0693-1
Strongman, H., Christopher, S., Majak, M., Williams, R., Bahmanyar, S., Linder, M., et al. (2018). Pioglitazone and cause-specific risk of mortality in patients with type 2 diabetes: extended analysis from a European multidatabase cohort study. BMJ Open Diabetes Res Care. http://doi.org/10.1136/bmjdrc-2017-000481